Chris Karapetis
Flinders Centre for Innovation in Cancer, SA, Australia
- This delegate is presenting an abstract at this event.
Professor Chris Karapetis is Network Director for Cancer Services in the Southern Area Local Health Network of Adelaide, Head of the Department of Medical Oncology and Director of Clinical Research in Oncology at the Flinders Medical Centre in Adelaide. Professor Karapetis has been the principal investigator on over 180 clinical trials and has published over 270 papers. He has established research interests in the areas of gastro-intestinal malignancy, lung cancer, molecular targeted therapies, predictive biomarkers and epidemiology. He is the current Chair of Scientific Advisory Committee of the AGITG. He is also Chair and Convenor of the Australia and Asia Pacific Clinical Research Development (ACORD) Initiative. He is a former Chair the Medical Oncology Group of Australia (MOGA), a past board member of COSA, and has served on NHMRC Grant Review Panels
Presentations this author is a contributor to:
ICECREAM: Irinotecan Cetuximab Evaluation and the Cetuximab Response Evaluation Among Patients with G13D Mutation (#328)
3:00 PM
Eva Segelov
Posters - Trials in progress
Immune Genetic Variability is Associated with Risk of Severe Gastrointestinal Toxicity in Patients Treated with Fluorouracil (#156)
3:20 PM
Joanne Bowen
Best of the Best Posters: Cancer side effects and symptoms
Late Effects of Oxaliplatin-induced peripheral Neuropathy (LEON) (#179)
3:00 PM
Jaein Lee
Posters - Clinical research
A Pilot Study of Tailored Nutrition and Physical Activity Intervention in Cancer Survivors (#280)
3:00 PM
Bogda Koczwara
Posters - Supportive care
A Pilot Study of a Healthy Lifestyle Self-Management Intervention with Cancer Survivors (#178)
3:00 PM
Sharon Lawn
Posters - Clinical research
Do we have to keep patients on treatment forever? When is it OK to stop? (#108)
9:00 AM
Chris Karapetis
Plenary: Conundrums in colorectal cancer